Altimmune, Inc. (ALT)

2.98 +0.05 (+1.71%) USD  |  NASDAQ  |  May 27, 16:00
3.00 +0.02 (+0.67%) After-Hours: 20:00
More

Altimmune Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
Amgen, Inc. Upgrade
Verastem, Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade